chlorogenic acid - Jiuzhang Biotech
Dupixent (dupilumab) - Sanofi, Regeneron
Interleukin-Mediated Macrophage Polarization in Allergic Rhinitis Inflammation: A Systematic Review. (PubMed, J Inflamm Res) - Jul 15, 2026 - "Targeted interventions (dupilumab, MCC950, chlorogenic acid) effectively reverse polarization imbalance and alleviate AR symptoms. IL-mediated macrophage polarization is a core driver of AR inflammation. Targeting these regulatory pathways provides promising precision therapeutic strategies for AR." 
Journal • Review • Allergic Rhinitis • Immunology • Inflammation • IL10 • IL13 • IL17A • IL1B • IL4 • IL6 • NLRP3 • STAT1 • STAT6
http://www.ncbi.nlm.nih.gov/pubmed/42445359
 
Haihuan Luan; Shouwei Gao; Xiaonan Li; Yuanyuan Ma; Zeyu Yu
 
Jul 15, 2026
 
Prev Next